Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

Nature Medicine

Volumn 2, Issue 5, 1996, Pages 551-555

  Heslop, Helen E ^a,b   Ng, Catherine Y C ^a   Li, Congfen ^a   Smith, Colton A ^a   Loftin, Susan K ^a   Krance, Roberta ^a,b   Brenner, Malcolm K ^a,b   Rooney, Cliona M ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; LYMPHOCYTE TRANSFER; PRIORITY JOURNAL; VIRUS INFECTION;

BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CHILD, PRESCHOOL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MALE; T-LYMPHOCYTES, CYTOTOXIC; TUMOR VIRUS INFECTIONS;

EID: 0029924619     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0596-551     Document Type: Article

References (25)

1. Kolb, H.J. et al. Graft-versus-leukemia effect of donor leukocyte infusions in marrow grafted patients. Blood 86, 2041-2050 (1995).
2. Papadopoulos, E.B. et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 330, 1185-1191 (1994).
3. Heslop, H.E., Brenner, M.K. & Rooney, C.M. Donor T cells to treat EBV-associated lymphoma. N. Engl. J. Med. 331, 679-680 (1994).
4. Walter, E.A. et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Eng. J. Med. 333, 1038-1044 (1995).
5. Rooney, C.M. et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 345, 9-13 (1995).
6. Riddell, S.R. & Greenberg, P.D. Principles for adoptive T cell therapy of human viral diseases. Annu. Rev. Immunol. 13, 545-586 (1995).
7. Smith, C.A. et al. Production of genetically modified EBV-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease. J. Hematother. 4, 73-79 (1995).
8. Reittie, J.E. et al. Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy. Blood 73, 1351-1358 (1989).
9. Bourgault, I., Gomez, A., Gomard, E. & Levy, J.P. Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes. Clin. Exp. Immunol. 84, 501-507 (1991).
10. Rooney, C.M. et al. Early identification of Epstein-Barr virus-associated post- - transplant lymphoproliferative disease. Br. J. Haematol. 89, 98-103 (1995).
11. Matloubian, M., Concepcion, R.J. & Ahmed, R. CD4+ T cells are required to sustain CD8+ cytotoxic T cell responses during chronic viral infection. J. Virol. 68, 8056-8063 (1994).
12. Oehen, S., Waldner, H., Kundig, T.M., Hengartner, H. & Zinkernagel, R.M. Antivirally protected cytotoxic T cell memory to lymphocytic choriomeningitis is governed by persisting antigen. J. Exp. Med. 176, 1273-1281 (1992).
13. Doherty, P.C., Hou, S. S: Tripp, R.A. CD8+ T-cell memory to viruses. Curr. Opin. Immunol. 6, 545-552 (1995).
14. Matzinger, P. Memories are made of this? Nature 369, 605-606 (1994).
15. Lucas, K., Small, T., O'Reilly, R.J. & Dupont, B. The development of Epstein Barr virus-specific cellular immunity following allogeneic bone marrow transplantation. Blood 84 (suppl.), 98a (1994).
16. Lau, L.L., Jamieson, B.D., Somasundaram, S. & Ahmed, R. Cytotoxic T-cell memory without antigen. Nature 369, 648-652 (1994).
17. Crystal, R.G. Transfer of genes to humans: Early lessons and obstacles to success. Science 270, 404-410 (1995).
18. Bordignon, C. et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270, 470-475 (1995).
19. Blaese, R.M. et al. T lymphocyte-directed gene therapy for ADA- SCID: Initial trial results after 4 years. Science 270, 475-480 (1995).
20. Nanda, N.K. & Sercarz, E.E. Induction of anti-self-immunity to cure cancer. Cell 82, 13-17 (1995).
21. Den Haan, J.M.M. et al. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 268, 1476-1480 (1995).
22. Heslop, H.E. et al. Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts. Hum. Gene Ther. 5, 381-397 (1994).
23. Rill, D.R. et al. An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer. Blood 79, 2694-2700 (1992).
24. Boyle, M.J. et al. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood 78, 3004-3011 (1991).
25. Zimber, U. et al. Geographical prevalence of two types of Epstein-Barr virus. Virology 154, 56-66 (1986).